Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes -: Early Treatment Diabetic Retinopathy Study Report no. 27

被引:136
|
作者
Cusick, M
Meleth, AD
Agrón, E
Fisher, MR
Reed, GF
Knatterud, GL
Barton, FB
Davis, MD
Ferris, FL
Chew, EY
机构
[1] NEI, NIH, Bethesda, MD 20892 USA
[2] NIH, Howard Hughes Med Inst, Bethesda, MD 20892 USA
[3] Univ Wisconsin, Dept Ophthalmol, Madison, WI USA
[4] Maryland Med Res Inst, Baltimore, MD USA
[5] EMMES, Rockville, MD USA
关键词
D O I
10.2337/diacare.28.3.617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Diabetes is a leading cause of morbidity and mortality. The purpose of this study is to assess the associations between diabetes complications and mortality in the Early Treatment Diabetic Retinopathy Study (ETDRS). RESEARCH DESIGN AND METHODS - We examined demographic, clinical, and laboratory characteristics of the 3,711 subjects enrolled in the ETDRS, a randomized controlled clinical trial designed to evaluate the role of laser photocoagulation and aspirin therapy for diabetic retinopathy. The outcome assessed was all-cause mortality. Multivariable Cox proportional hazards regression was used to assess associations between diabetes complications and mortality for type 1 and type 2 diabetes separately. RESULTS - The 5-year estimates of all-cause mortality were 5.5 and 18.9% for patients with type 1 and type 2 diabetes, respectively. In patients with type 1 diabetes, amputation (hazard ratio [HR] 5.08 [95% CI 2.06-12.54]) and poor visual acuity (1.74 [1.10-2.75]) remained significantly associated with mortality, after adjusting for other diabetes complication's and baseline characteristics. In patients with type 2 diabetes, macrovascular disease and worsening levels of nephropathy, neuropathy, retinopathy, and visual acuity are associated with progressively increasing risks of mortality, after controlling for other baseline risk factors. CONCLUSIONS - Amputation is the strongest predictor for mortality in. patients. with type 1 diabetes. All complications independently predict mortality in patients with type 2 diabetes. There is an increased risk for mortality as the degree of each complication worsens. Additional studies are needed to investigate the effectiveness of tertiary prevention to decrease mortality in these patients.
引用
收藏
页码:617 / 625
页数:9
相关论文
共 50 条
  • [21] Early Diabetic Nephropathy and Retinopathy in Patients with Type 1 Diabetes Mellitus Attending Sudan Childhood Diabetes Centre
    Ahmed, Hana
    Elshaikh, Tayseer
    Abdullah, Mohamed
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [22] Is diabetic retinopathy affected by diabetes type? A retrospective study using electronic medical record data from patients with latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes
    Wanyue Li
    Zifang Cheng
    Yanan Song
    Yifan Fang
    Ming Yang
    Maonian Zhang
    Acta Diabetologica, 2021, 58 : 1503 - 1511
  • [23] Is diabetic retinopathy affected by diabetes type? A retrospective study using electronic medical record data from patients with latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes
    Li, Wanyue
    Cheng, Zifang
    Song, Yanan
    Fang, Yifan
    Yang, Ming
    Zhang, Maonian
    ACTA DIABETOLOGICA, 2021, 58 (11) : 1503 - 1511
  • [24] Early predictors of diabetic retinopathy in type 1 diabetes: The Retinopathy Champagne Ardenne Diabete (ReCAD) study
    Diallo, Alpha Mamadou
    Novella, Jean-Luc
    Lukas, Celine
    Souchon, Pierre-Francois
    Drame, Moustapha
    Francois, Maud
    Decoudier, Benedicte
    Barraud, Sara
    Salmon, Anne-Sophie
    Ancelle, Deborah
    Arndt, Carl
    Delemer, Brigitte
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (08) : 753 - 758
  • [25] Diabetic Retinopathy and Cognitive Decline in Older People With Type 2 Diabetes The Edinburgh Type 2 Diabetes Study
    Ding, Jie
    Strachan, Mark W. J.
    Reynolds, Rebecca M.
    Frier, Brian M.
    Deary, Ian J.
    Fowkes, F. Gerald R.
    Lee, Amanda J.
    McKnight, Janet
    Halpin, Patricia
    Swa, Ken
    Price, Jackie F.
    DIABETES, 2010, 59 (11) : 2883 - 2889
  • [26] Early retinal functional alteration in relation to diabetes duration in patients with type 2 diabetes without diabetic retinopathy
    Srinivasan, Sangeetha
    Sivaprasad, Sobha
    Rajalakshmi, Ramachandran
    Anjana, Ranjit Mohan
    Malik, Rayaz A.
    Kulothungan, Vaitheeswaran
    Natarajan, Viswanathan
    Raman, Rajiv
    Bhende, Muna
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [27] Early retinal functional alteration in relation to diabetes duration in patients with type 2 diabetes without diabetic retinopathy
    Sangeetha Srinivasan
    Sobha Sivaprasad
    Ramachandran Rajalakshmi
    Ranjit Mohan Anjana
    Rayaz A. Malik
    Vaitheeswaran Kulothungan
    Viswanathan Natarajan
    Rajiv Raman
    Muna Bhende
    Scientific Reports, 12
  • [28] Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy
    Dong, Ning
    Xu, Bing
    Wang, Bingsong
    Chu, Liqun
    MOLECULAR VISION, 2013, 19 : 1734 - 1746
  • [29] EARLY MICROVASCULAR AND NEURAL CHANGES IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS WITHOUT CLINICAL SIGNS OF DIABETIC RETINOPATHY
    Vujosevic, Stela
    Muraca, Andrea
    Alkabes, Micol
    Villani, Edoardo
    Cavarzeran, Fabiano
    Rossetti, Luca
    De Cilla, Stefano
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (03): : 435 - 445
  • [30] Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes
    Barrot, Joan
    Real, Jordi
    Vlacho, Bogdan
    Romero-Aroca, Pedro
    Simo, Rafael
    Mauricio, Didac
    Mata-Cases, Manel
    Castelblanco, Esmeralda
    Mundet-Tuduri, Xavier
    Franch-Nadal, Josep
    FRONTIERS IN MEDICINE, 2022, 9